Journal of Nutrition and Metabolism / 2012 / Article / Tab 1 / Clinical Study
Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial Table 1 Demographic characteristics in two groups.
Carnitine Placebo
š
š
=
2
4
š
=
2
7
Age (year)
5
3
.
9
Ā±
1
7
.
2
5
1
.
8
Ā±
1
3
.
5
0.627 Gender āMale
1
2
(
5
0
%
)
1
4
(
5
1
.
8
%
)
0.559 āFemale
1
2
(
5
0
%
)
1
3
(
4
8
.
1
%
)
BMI
2
3
.
0
Ā±
4
.
3
2
5
.
4
Ā±
3
.
6
0.383 Hemodialysis (month)
3
2
.
5
Ā±
2
5
.
9
2
8
.
1
Ā±
1
3
.
3
0.441 Etiology of ESRD āDiabetes
1
2
(
5
0
%
)
1
5
(
5
5
.
5
%
)
0.645 āHypertension
6
(
2
5
%
)
6
(
2
2
.
2
%
)
āPolycystic kidney
1
(
4
.
1
%
)
3
(
1
1
.
1
%
)
āMiscellaneous
5
(
2
0
.
8
%
)
3
(
1
1
.
1
%
)
